Clinical trial
Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate…
NCT00121784 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00121784 |
|---|---|
| Title | Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients |
| Official title | A Randomized, Open-label Study of the Effect of Replacing CNI With Sirolimus in a Standard Care Regimen of CNI, CellCept, and Steroids on Renal Function in Heart Transplant Patients |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Transplantation |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil [CellCept] |
| Enrollment | 12 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jul 21, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | Australia, Austria, France, Germany, Spain, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: